News and Press Releases Search About the CF Foundation CFTR Modulators Public Policy Research Advocacy Drug Pipeline North American CF Conference Care Centers CF Related Health Conditions Clinical Trials Fundraising Health Care Reform (-) Genetic Therapies 2016 2015 2014 2013 2012 (-) 2011 2009 2008 2006 News Press Releases About the CF Foundation | CFTR Modulators | Genetic Therapies FDA Grants Six-Month Priority Review of Kalydeco (VX-770) — First Potential Drug to Target Underlying Cause of Cystic Fibrosis Dec. 15, 2011 | 2 min read About the CF Foundation | Drug Pipeline | Genetic Therapies Genzyme and Cystic Fibrosis Foundation Therapeutics Announce Collaboration to Discover New CF Drugs New Effort Will Search for Potential Therapies Targeting the Most Common Mutation of Cystic Fibrosis Nov. 16, 2011 | 4 min read About the CF Foundation | CFTR Modulators | Genetic Therapies New Hope of Kalydeco (VX-770) Makes Headlines and Newscasts Around the Nation Nov. 8, 2011 | 2 min read About the CF Foundation | CFTR Modulators | Genetic Therapies Cystic Fibrosis Foundation Issues Statement on The New England Journal of Medicine Study Showing Evidence of Success in Treating Underlying Cause of Cystic Fibrosis Nov. 2, 2011 | 2 min read About the CF Foundation | CFTR Modulators | Genetic Therapies Wall Street Journal Health Blog: CF Foundation Not Just a Cheerleader Oct. 25, 2011 | 2 min read About the CF Foundation | CFTR Modulators | Genetic Therapies New Cystic Fibrosis Drug Brings Gift of a Future, NPR Reports Online May. 6, 2011 | 1 min read About the CF Foundation | CFTR Modulators | Genetic Therapies Bloomberg Businessweek Highlights Promise of Potential Drug VX-770 Mar. 22, 2011 | 2 min read About the CF Foundation | CFTR Modulators | Genetic Therapies The New York Times and Other Major Media Outlets Feature Results of VX-770 Trial Mar. 4, 2011 | 2 min read
